EUVIMEDObjevte EUVIMED
Crossref

Cardiac amyloidosis and implantable cardioverter‑defibrillator implantation — should threshold criteria be reconsidered in the absence of classical indications?

Raman Zhdanovich, Aleksey Goshev, Uladzislau Shyshko, Volga Vrubleuskaya

Medical Research Journal · 2026-01-15 · 11

DOI: 10.5603/mrj.110313 ↗

At a glance

Journal article in Medical Research Journal, published online on 2026-01-15. Written by Raman Zhdanovich and 3 co-authors.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Cite

APA

Zhdanovich, R., Goshev, A., Shyshko, U., & Vrubleuskaya, V. (2026). Cardiac amyloidosis and implantable cardioverter‑defibrillator implantation — should threshold criteria be reconsidered in the absence of classical indications?. Medical Research Journal, 11(0). https://doi.org/10.5603/mrj.110313

Vancouver

Zhdanovich R, Goshev A, Shyshko U, Vrubleuskaya V. Cardiac amyloidosis and implantable cardioverter‑defibrillator implantation — should threshold criteria be reconsidered in the absence of classical indications?. Medical Research Journal. 2026;11(0). doi:10.5603/mrj.110313

BibTeX
@article{Zhdanovich2026,
  author = {Zhdanovich, Raman and Goshev, Aleksey and Shyshko, Uladzislau and Vrubleuskaya, Volga},
  title = {Cardiac amyloidosis and implantable cardioverter‑defibrillator implantation — should threshold criteria be reconsidered in the absence of classical indications?},
  journal = {Medical Research Journal},
  year = {2026},
  volume = {11},
  number = {0},
  doi = {10.5603/mrj.110313}
}
Start for free →